	PMID	PT	OT	MH	SI	TI	GR
0	32497632	Journal Article;Review		Aminoquinolines/therapeutic use;AntiBacterial Agents/therapeutic use;Antiviral Agents/therapeutic use;Betacoronavirus/*isolation & purification;COVID19;COVID19 Vaccines;Coronavirus Infections/*drug therapy/prevention & control/virology;Drug Repositioning;Humans;Pandemics;Pneumonia, Viral/*drug therapy/virology;SARSCoV2;Viral Vaccines/administration & dosage;DA 2020/08/25 06:00		Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical 	
1	32560227	Journal Article;Review	O  NNLM;COVID19;SARSCoV2;coronavirus;therapies;vaccines	DA 2020/06/21 06:01		Vaccines and Therapies in Development for SARS-CoV-2 Infections.	R01AI13976802/National Institute of Allergy and Infectious Diseases/
2	32916249	Editorial	O  NNLM;SARSCoV2;control;diagnostics;hygiene;therapeutics;vaccination	COVID19/diagnosis/drug therapy/*prevention & control;COVID19 Serological Testing;COVID19 Vaccines/immunology;Delivery of Health Care;Hand Disinfection;*Health Resources;Humans;RealTime Polymerase Chain Reaction;*SARSCoV2;DA 2021/01/01 06:00		Integrated control of COVID-19 in resource-poor countries.	
3	32784499	Journal Article;Review	O  NNLM;COVID19;SARSCoV2;antiviral;coronavirus;remdesivir;vaccine	DA 2020/08/14 06:01		Emerging Therapeutic Modalities against COVID-19.	1R01CA24119401A1/NH/NIH HHS/United States;1R01HL14702801A1/NH/NIH HHS/United States
4	32871201	Journal Article;Research Support, N.I.H., Extramural;Review	O  NNLM;*Bioinspired materials;*Drug delivery;*Hierarchical selfassembly;*Polypeptides;*Recombinant proteins	DA 2020/09/02 06:00		Recent trends in protein and peptide-based biomaterials for advanced drug delivery.	R35 GM127042/GM/NIGMS NIH HHS/United States;R21 CA237705/CA/NCI NIH HHS/United States
5	32562159	Comparative Study;Journal Article;Observational Study	O  NNLM;Combination therapy;Coronavirus disease 2019;Length of stay in hospitals (ALOS)	Adult;Aged;Azithromycin/administration & dosage;COVID19/complications/*drug therapy;Drug Combinations;Drug Therapy, Combination;Female;Hospitalization/*statistics & numerical data;Humans;Hydroxychloroquine/administration & dosage;Iran;Length of Stay;Levofloxacin/administration & dosage;Lopinavir/administration & dosage;Male;Meropenem/administration & dosage;Middle Aged;Naproxen/administration & dosage;Oseltamivir/administration & dosage;Pneumonia, Viral/*drug therapy/virology;Prednisolone/administration & dosage;Retrospective Studies;Ritonavir/administration & dosage;Treatment Outcome;Vancomycin/administration & dosage;DA 2020/12/15 06:00		The clinical value of two combination regimens in the Management of Patients 	
6	32814759	Journal Article;Research Support, NonU.S. Gov't		Animals;Antiviral Agents/pharmacology;Betacoronavirus/*physiology;COVID19;Cell Death/drug effects;Chlorocebus aethiops;Coronavirus Infections/*metabolism/virology;Drug Evaluation, Preclinical/*methods;Hydroxychloroquine/pharmacology;Imatinib Mesylate/pharmacology;Lysosomes/drug effects;Pandemics;Pneumonia, Viral/*metabolism/virology;Protein Kinase Inhibitors/pharmacology;RNA, Viral/drug effects;SARSCoV2;Vero Cells;Viral Load/drug effects;Virus Replication/*drug effects;DA 2020/09/02 06:00		On-target versus off-target effects of drugs inhibiting the replication of 	
7	33055059	Journal Article	O  NNLM;2019nCoV;COVID19;SARS;SARSCoV2;coronavirus;dexamethasone;hydroxychloroquine;ivermectin;remdesivir;statin;statins	DA 2020/10/16 06:01		Toward Preparing a Knowledge Base to Explore Potential Drugs and Biomedical Entities 	
8	33324210	Journal Article	O  NNLM;COVID19;coronavirus;cytokine storm;fibrosis;macrophage	DA 2020/12/17 06:01		Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019.	
9	32717568	Journal Article;Review	O  NNLM;*Chloroquine;*Coronavirus;*Lopinavir;*Remdesivir;*Ribavirin;*Ritonavir;*SARSCoV2	Animals;AntiBacterial Agents/administration & dosage/metabolism;Antibodies, Monoclonal, Humanized/administration & dosage/metabolism;Antimalarials/administration & dosage/metabolism;Antiviral Agents/*administration & dosage/metabolism;COVID19/*drug therapy/metabolism;Clinical Trials as Topic/methods;Cytochrome P450 CYP3A Inhibitors/administration & dosage/metabolism;Drug Approval/*methods;Drug Therapy, Combination;Humans;Hydroxychloroquine/administration & dosage/metabolism;SARSCoV2/*drug effects/metabolism;United States/epidemiology;DA 2020/12/29 06:00		FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) 	
10	33178016	Journal Article;Review	O  NNLM;Middle East respiratory syndrome coronavirus;coronavirus;coronavirus disease 2019;severe acute respiratory syndrome coronavirus2;therapeutic interventions;transmission	DA 2020/11/13 06:01		COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future 	
11	32977703	Journal Article;Review	O  NNLM;Aedes;Flavivirus;Zika;dengue;epidemiology	DA 2020/09/27 06:01		Dengue and Zika Viruses: Epidemiological History, Potential Therapies, and Promising 	"N.M.S. acknowledges FCTMCTES fellowship SFRH/BD/144585/2019/Fundação para a Ciência ;I.C.M. acknowledges FCTMCTES program ""Concurso de Estímulo ao Emprego Científico"" ;I.C.M. acknowledges support from Science Frontiers Research Prize of 2010/Fundação "
12	33024717	Journal Article;Review	O  NNLM;Antiviral drugs;COVID19;Coronavirus;Eculizumab;Enoxaparin;Hydroxychloroquine;Opinion review;Pandemic;SARSCoV2;Tocilizumab;Treatment	DA 2020/10/08 06:01		Current status of COVID-19 treatment: An opinion review.	
13	32344679	Journal Article;Review	O  NNLM;COVID19;One Health;SARSCoV2;control;diagnosis;epidemiology;genetics;outbreak;pneumonia;public health;treatment	DA 2020/04/30 06:01		The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, 	
14	32711111	Journal Article;Review	O  NNLM;*ACE2;*Ang (17);*Covid19;*Immunomodulators;*Remdesivir;*SARSCoV2	AngiotensinConverting Enzyme 2;Antiviral Agents/*therapeutic use;Betacoronavirus/chemistry/*metabolism;COVID19;Coronavirus Infections/*drug therapy/prevention & control/virology;Drug Repositioning/*methods;Humans;Life Cycle Stages/*drug effects;Molecular Targeted Therapy/*methods;Pandemics/prevention & control;PeptidylDipeptidase A/metabolism;Pneumonia, Viral/*drug therapy/prevention & control/virology;ReninAngiotensin System/drug effects;SARSCoV2;Spike Glycoprotein, Coronavirus/immunology/metabolism;Viral Vaccines/immunology;Virus Internalization/drug effects;Virus Replication/drug effects;DA 2020/09/10 06:00		Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising 	
15	33132570	Journal Article;Review	O  NNLM;Coronavirus;Coronavirus disease2019;Heparin;Hydroxychloroquine;Remdesvir;SARSCoV2;Tocilizumab	DA 2020/11/03 06:01		Current Approaches to COVID-19: Therapy and Prevention.	
16	33398233	Journal Article;Review		DA 2021/01/06 06:01		Novel coronavirus disease (COVID-19) pandemic: A recent mini review.	
17	33482149	Journal Article;Review	O  NNLM;*COVID19;*Drug safety and drug efficacy;*Mutation;*RNA therapeutics;*SARSCoV2	DA 2021/01/23 06:00		Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts 	
18	32768971	Journal Article;Review	O  NNLM;Anakinra;Convalescent plasma;Corticosteroids;Hydroxychloroquine;SARSCoV2;Vaccine	Animals;Antiviral Agents/*pharmacology;Betacoronavirus/drug effects/isolation & purification;COVID19;Coronavirus Infections/*drug therapy/epidemiology/virology;Drug Design;Humans;Pandemics;Pneumonia, Viral/*drug therapy/epidemiology/virology;Public Health;SARSCoV2;Viral Vaccines/administration & dosage;DA 2020/09/08 06:00		Natural history of COVID-19 and current knowledge on treatment therapeutic options.	
19	32903349	Journal Article;Review	O  NNLM;COVID19;SARSCoV2;antivirals;coronaviruses;treatment	DA 2020/09/10 06:01		Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?	
20	32756480	Journal Article;Review	O  NNLM;COVID19;MERSCoV;SARSCoV;SARSCoV2;adjunctive therapy;antiparasite;antiviral;clinical trial;immunotherapy;molecular immune response	*Adaptive Immunity;AntiInflammatory Agents/therapeutic use;Antiviral Agents/therapeutic use;Betacoronavirus/isolation & purification/*physiology;COVID19;Coronavirus Infections/immunology/*pathology/therapy/virology;Humans;Immunotherapy;Middle East Respiratory Syndrome Coronavirus/isolation & purification/physiology;Open Reading Frames/genetics;Pandemics;Pneumonia, Viral/immunology/*pathology/therapy/virology;SARSCoV2;DA 2020/08/13 06:00		COVID-19: The Immune Responses and Clinical Therapy Candidates.	
21	32868970	Journal Article;Review	O  NNLM;Antiinflammatory agents;Antiviral drugs;COVID19;Corona virus;SARSCoV2	DA 2020/09/02 06:01		Novel β-Coronavirus (SARS-CoV-2): Current and future aspects of pharmacological 	
22	33227287	Journal Article;Review	O  NNLM;COVID19;Repurposed drugs;SARSCoV2;Therapeutic targets;Vaccines	Adrenal Cortex Hormones/*therapeutic use;Animals;Antiviral Agents/*therapeutic use;COVID19/*drug therapy/epidemiology/*therapy;Drug Repositioning;Epidemics;Humans;Immunization, Passive;*Medicine, Ayurvedic;*Medicine, Chinese Traditional;*SARSCoV2/immunology;Viral Vaccines;DA 2020/12/30 06:00		A comprehensive review on potential therapeutics interventions for COVID-19.	
23	33317461	Journal Article;Randomized Controlled Trial	O  NNLM;Arbidol;COVID19;Corona virus;Efficacy	Adult;Aged;Antiviral Agents/*therapeutic use;COVID19/*drug therapy;Drug Combinations;Female;Humans;Hydroxychloroquine/therapeutic use;Indoles/*therapeutic use;Lopinavir/therapeutic use;Male;Middle Aged;Pandemics;Ritonavir/therapeutic use;SARSCoV2;DA 2020/12/19 06:00		Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial.	17640/Iran University of Medical Sciences/
24	33191206	Journal Article;Review		Adenosine Monophosphate/analogs & derivatives/chemistry/pharmacology/therapeutic use;Alanine/analogs & derivatives/chemistry/pharmacology/therapeutic use;AntiInflammatory Agents/chemistry/pharmacology/*therapeutic use;Antioxidants/chemistry/pharmacology/*therapeutic use;Antiviral Agents/chemistry/pharmacology/*therapeutic use;COVID19/*drug therapy;Drug Repositioning/*methods/trends;Humans;SARSCoV2/*drug effects;Treatment Outcome;Virus Internalization/drug effects;DA 2021/01/14 06:00		Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A 	
25	33041814	Journal Article;Review	O  NNLM;COVID19 proposed therapy;Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV2);convalescent plasma;pandemic;therapeutic challenges	DA 2020/10/13 06:01		Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future 	
26	33473151	Journal Article;Research Support, N.I.H., Extramural;Research Support, NonU.S. Gov't		Antiviral Agents/chemistry/*pharmacology;COVID19/*drug therapy/virology;Coronavirus 3C Proteases/*antagonists & inhibitors/chemistry/metabolism;Cysteine Proteinase Inhibitors/chemistry/*pharmacology;*Drug Discovery;Humans;Ligands;Molecular Docking Simulation;Molecular Dynamics Simulation;Protein Binding;Protein Conformation;SARSCoV2/*drug effects/enzymology;StructureActivity Relationship;Virus Replication/*drug effects;DA 2021/01/28 06:00		Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential 	R03 AI128254/AI/NIAID NIH HHS/United States;1R03 AI12825401A1/Division of Intramural Research, National Institute of Allergy 
27	33072869	Journal Article	O  NNLM;COVID;Hospitalized;Mortality;SARSCoV2;Treatments	DA 2020/10/20 06:01		Therapeutic agents tested in 238 COVID-19 hospitalized patients and their 	
28	32956644	Journal Article;Review	O  NNLM;Medications;Novel corona virus;SARSCoV2	AntiInflammatory Agents/pharmacology/therapeutic use;Antiviral Agents/pharmacology/therapeutic use;COVID19;Chloroquine/analogs & derivatives/therapeutic use;Coronavirus Infections/*drug therapy/*physiopathology;DNADirected RNA Polymerases/antagonists & inhibitors;Humans;Pandemics;Pneumonia, Viral/*drug therapy/*physiopathology;DA 2020/11/06 06:00		A review of medications used to control and improve the signs and symptoms of 	
29	33035643	Journal Article;Research Support, NonU.S. Gov't;Review	O  NNLM;*COVID19;*HIV;*Molecular mechanisms;*Origin and taxonomy;*Potential therapeutics	Antiviral Agents/pharmacology/therapeutic use;COVID19/drug therapy/*epidemiology/virology;China;Drug Repositioning;HIV/*classification/genetics/immunology;HIV Infections/drug therapy/*epidemiology/virology;Humans;Pandemics/prevention & control;Phylogeny;SARSCoV2/*classification/genetics/immunology;DA 2020/12/15 06:00		Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and 	
30	32329520	Journal Article;Review	O  NNLM;*COVID19;*antiinflammatory agents;*antivirals;*clinical practice;*clinical research;*immunomodulatory agents;*pharmacological treatments	Animals;Antiviral Agents/*administration & dosage/adverse effects/pharmacology;Betacoronavirus/isolation & purification;COVID19;Coronavirus Infections/*drug therapy/virology;Drug Repositioning;Humans;Pandemics;Pneumonia, Viral/*drug therapy/virology;SARSCoV2;DA 2020/10/28 06:00		Current pharmacological treatments for COVID-19: What's next?	
31	32346490	Journal Article	O  NNLM;COVID19 outbreak;CoVMpro;CoVNsp12 polymerase;CoVNsp13 helicase;SARSCoV2	DA 2020/04/30 06:01		Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal 	
32	32992245	Journal Article;Research Support, NonU.S. Gov't	O  NNLM;*Antiviral;*COVID19;*Coronavirus;*Repurposed drugs;*SARSCoV2	Antiviral Agents/chemistry/*therapeutic use;COVID19/immunology/*therapy;COVID19 Vaccines/*immunology;*Drug Repositioning;Humans;SARSCoV2/*drug effects/immunology;DA 2020/12/22 06:00		COVID-19 therapy: What weapons do we bring into battle?	
33	32880078	Journal Article;Review	O  NNLM;COVID19;Computational;Coronavirus;Drug;SARSCoV2;Vaccine	Animals;Antiviral Agents/*therapeutic use;COVID19/*drug therapy/virology;Computational Biology/methods;Drug Discovery/methods;Drug Repositioning/methods;Humans;Pandemics/prevention & control;SARSCoV2/*drug effects;DA 2021/02/18 06:00		Therapeutics for COVID-19: from computation to practices-where we are, where we are 	
34	32838187	Journal Article;Review	O  NNLM;Diagnosis;Lopinavir/ritonavir;Novel coronavirus pneumonia;Treatment	DA 2020/08/25 06:00		Protease Inhibitor Use in COVID-19.	
35	32322397	Journal Article;Review	O  NNLM;Azithromycin;COVID19;coronavirus;hydroxychloroquine;ivermectin	DA 2020/04/24 06:01		Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting 	
36	32748244	Journal Article;Review	O  NNLM;COVID19;SARSCoV2;diagnosis;pandemic;public health;treatment strategies	Antiviral Agents/therapeutic use;*Betacoronavirus;COVID19;Coronavirus Infections/*diagnosis/*therapy;Humans;Immunization, Passive/trends;Nucleic Acid Amplification Techniques/methods/trends;Pandemics/*prevention & control;Pneumonia, Viral/*diagnosis/*therapy;RealTime Polymerase Chain Reaction/methods/trends;SARSCoV2;DA 2020/08/11 06:00		Diagnostic and Treatment Strategies for COVID-19.	
37	32854988	Journal Article;Review	O  NNLM;*ARDSCoV2;*COVID19;*ICU;*SARSCoV2;*Tratamiento;*Treatment;*UCI	Adenosine Monophosphate/analogs & derivatives/therapeutic use;Adrenal Cortex Hormones/therapeutic use;Alanine/analogs & derivatives/therapeutic use;Antibodies, Monoclonal/therapeutic use;Antibodies, Monoclonal, Humanized/therapeutic use;Anticoagulants/therapeutic use;Antiviral Agents/therapeutic use;Azithromycin/therapeutic use;COVID19/*drug therapy/therapy;Disease Progression;Humans;Hydroxychloroquine/therapeutic use;Immunization, Passive;Immunoglobulins, Intravenous/therapeutic use;Immunomodulation;Interferonbeta/therapeutic use;Interleukin 1 Receptor Antagonist Protein/therapeutic use;Lopinavir/therapeutic use;Protein Kinase Inhibitors/therapeutic use;Pyrazoles/therapeutic use;Ritonavir/therapeutic use;*SARSCoV2;DA 2021/03/11 06:00		Pharmacological treatment of COVID-19: Narrative review of the Working Group in 	
38	32777212	Journal Article	O  NNLM;Anticoagulants;Antivirals;Chloroquine;Dexamethasone;Ivermectin	AntiInflammatory Agents/therapeutic use;Antimalarials/therapeutic use;Antiviral Agents/*therapeutic use;COVID19;Coronavirus Infections/*drug therapy;Dexamethasone/therapeutic use;Humans;In Vitro Techniques;Pandemics;Pneumonia, Viral/*drug therapy;DA 2020/11/06 06:00		What to expect from different drugs used in the treatment of COVID-19: A study on 	
39	33389724	Journal Article;Review	O  NNLM;Antiviral;COVID19;Drug repurposing;SARSCoV2;Target proteins	DA 2021/01/04 06:00		SARS-CoV-2 therapeutics: how far do we stand from a remedy?	
40	33530467	Journal Article;Review	O  NNLM;COVID19;SARSCoV2;clinical trials;drug repurposing;in silico;in vitro;in vivo;multitargeting;natural products	*Antiviral Agents/chemistry/therapeutic use;COVID19/*drug therapy/epidemiology/metabolism;*Drug Delivery Systems;Humans;Pandemics;*SARSCoV2/chemistry/metabolism;DA 2021/02/09 06:00		Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable 	
41	32358833	Journal Article;Research Support, NonU.S. Gov't;Review		Animals;Antiviral Agents/*administration & dosage/pharmacology;Betacoronavirus/isolation & purification;COVID19;Coronavirus Infections/*drug therapy/virology;Drug Development;Drug Discovery;Drug Repositioning;Humans;Pandemics;Pneumonia, Viral/*drug therapy/virology;SARSCoV2;DA 2020/10/28 06:00		A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and 	Award Ref TG/18/4/33770/AF03 British Heart Foundation Translational/International;107715/Z/15/Z/WT_/Wellcome Trust/United Kingdom
42	33397429	Clinical Trial Protocol;Letter	O  NNLM;COVID19;Clinical symptoms;Hospitalization Mechanical ventilation;Ivermectin;Protocol;Randomized controlled trial	Administration, Oral;Adult;Antiviral Agents/*administration & dosage/adverse effects;COVID19/diagnosis/*drug therapy/virology;Clinical Trials, Phase III as Topic;Drug Therapy, Combination/adverse effects/methods;Female;Humans;Hydroxychloroquine/administration & dosage/adverse effects;Intensive Care Units/statistics & numerical data;Interferon beta1a/administration & dosage/adverse effects;Iran;Ivermectin/*administration & dosage/adverse effects;Length of Stay/statistics & numerical data;Lopinavir/administration & dosage/adverse effects;Male;Randomized Controlled Trials as Topic;Ritonavir/administration & dosage/adverse effects;SARSCoV2/drug effects/*isolation & purification;Severity of Illness Index;DA 2021/01/13 06:00		The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A 	990238/Hormozgan University of Medical Sciences/
43	32499154	Journal Article;Review	O  NNLM;*Human coronavirus;*SARSCoV2;*Structure;*Therapy;*Treatments;*Virus	Animals;Betacoronavirus/drug effects/physiology;COVID19;Clinical Trials as Topic;Coronavirus Infections/drug therapy/*epidemiology/*therapy;Genome, Viral;Global Health;HostPathogen Interactions;Humans;Ligands;Pandemics;Pneumonia, Viral/*epidemiology/*therapy;Risk;SARSCoV2;Virus Replication;DA 2020/09/29 06:00		Covid-19 Pandemic and Current Medical Interventions.	
44	32423024	Journal Article;Review	O  NNLM;ACE2;COVID19;SARSCoV2;TMPRSS2;baricitinib;chloroquine;favipiravir;interferons;lopinavir;remdesivir	DA 2020/05/20 06:01		The Rationale for Potential Pharmacotherapy of COVID-19.	
45	32708302	Journal Article;Review	O  NNLM;NFκB pathway;anticancer;antiinflammatory;autoimmune disease;clinical trials;small molecules	AntiInflammatory Agents/*pharmacology;Antineoplastic Agents/*pharmacology;Drug Discovery/*methods;Humans;Ikappa B Kinase/antagonists & inhibitors/*metabolism;NFkappa B/antagonists & inhibitors/*metabolism;Proteasome Inhibitors/pharmacology;Signal Transduction/*drug effects/genetics;Ubiquitination/drug effects;DA 2021/03/05 06:00		Small Molecule NF-κB Pathway Inhibitors in Clinic.	NRFCRP17201702/National Research Foundation Singapore/
46	32391242	Journal Article;Review	O  NNLM;Biomarkers;COVID19;Coronavirus management algorithm;Precision medicine	DA 2020/05/12 06:00		A Precision Medicine Approach to SARS-CoV-2 Pandemic Management.	
47	33058394	Journal Article	O  NNLM;COVID19;SARSCoV2;antiviral drugs;therapeutic targets	Antiviral Agents/*pharmacology/therapeutic use;COVID19/*drug therapy/immunology/virology;Humans;Immune System Phenomena/*drug effects;SARSCoV2/*drug effects/immunology/metabolism/pathogenicity;DA 2020/12/19 06:00		SARS-CoV-2 virus infection: Targets and antiviral pharmacological strategies.	Finance Code 001./Coordenação de Aperfeiçoamento de Pessoal de Nível Superior/
48	33288313	Journal Article	O  NNLM;Aerosol;Coronavirus;Covid19;Mouthrinses;Mouthwashes;SARSCoV2	Aerosols;Antiviral Agents/therapeutic use;COVID19/prevention & control/*transmission/*virology;Dental Auxiliaries;Dentists;Disease Reservoirs/virology;Humans;In Vitro Techniques;Infectious Disease Transmission, PatienttoProfessional/*prevention & control;*Models, Biological;Mouthwashes/chemistry/*therapeutic use;Oropharynx/virology;Pandemics/prevention & control;Randomized Controlled Trials as Topic/methods;SARSCoV2/genetics/*isolation & purification/pathogenicity;Saliva/virology;*Viral Load;DA 2021/01/29 06:00		Can preprocedural mouthrinses reduce SARS-CoV-2 load in dental aerosols?	
49	33482181	Journal Article;Review	O  NNLM;2019nCoV;COVID19;Drug repositioning;Outbreak;Review;SARSCoV2	Animals;Antiviral Agents/*therapeutic use;COVID19/*drug therapy/virology;Humans;Pandemics/prevention & control;SARSCoV2/*drug effects;DA 2021/02/23 06:00		A review of potential suggested drugs for coronavirus disease (COVID-19) treatment.	
50	32848795	Journal Article;Review	O  NNLM;COVID19;SARSCoV2;adjunctive therapy;antivirals;therapeutics	DA 2020/08/28 06:01		COVID-19 Therapeutic Options Under Investigation.	
51	33476760	Journal Article;Review	O  NNLM;Antivirals;COVID19;Clinical trials;Immunomodulators;Prevention;SARSCoV2;Vaccines	Antiviral Agents/therapeutic use;COVID19/*prevention & control;*Clinical Trials as Topic;*Drug Development;*Drug Repositioning;Humans;Immunologic Factors/therapeutic use;SARSCoV2;Vaccines/therapeutic use;DA 2021/04/24 06:00		Pharmacological strategies to prevent SARS-CoV-2 infection and treat the early 	
52	32702077	Preprint		DA 2020/07/24 06:01		Identification of new drug treatments to combat COVID19: A signature-based approach 	R01 MH107487/MH/NIMH NIH HHS/United States;R01 MH121102/MH/NIMH NIH HHS/United States
53	32878641	Journal Article;Review	O  NNLM;COVID19;Immunotherapeutics;SARSCoV2;Therapeutics;Vaccines	Antiviral Agents/*therapeutic use;Betacoronavirus;China/epidemiology;Coronavirus/*immunology;Coronavirus Infections/*drug therapy/epidemiology/*prevention & control;Humans;Pandemics/*prevention & control;SARSCoV2;Severe Acute Respiratory Syndrome/*drug therapy/epidemiology;Vaccines/*therapeutic use;DA 2020/09/10 06:00		SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines 	
54	32926918	Journal Article;Review	O  NNLM;COVID19;Clinical trials;Pathophysiology;Pharmacotherapy;SARSCov2	COVID19;Clinical Trials as Topic;Coronavirus Infections/*complications/*drug therapy;Humans;Molecular Targeted Therapy/*methods;Pandemics;Pneumonia, Viral/*complications/*drug therapy;DA 2020/10/27 06:00		COVID-19 associated complications and potential therapeutic targets.	
55	32889701	Journal Article;Review	O  NNLM;COVID19;Coronavirus;Repurposing;SARSCoV2	Animals;Antiviral Agents/pharmacology/*therapeutic use;COVID19/*drug therapy/virology;Computer Simulation;Drug Discovery/methods;*Drug Repositioning;Humans;SARSCoV2/drug effects/pathogenicity;DA 2020/12/15 06:00		Drug repurposing approach to fight COVID-19.	
56	32293834	Journal Article;Review	O  NNLM;*Covid19;*SarsCoV2;*antiviral	Adenosine Monophosphate/analogs & derivatives;Alanine/analogs & derivatives;Amides;Antiviral Agents/*therapeutic use;Betacoronavirus;COVID19;Chloroquine;Coronavirus Infections/*drug therapy;Drug Combinations;Humans;Hydroxychloroquine;Ivermectin;Lopinavir;Pandemics;Pneumonia, Viral/*drug therapy;Pyrazines;Ritonavir;SARSCoV2;Thiazoles;DA 2020/04/23 06:00		Antiviral treatment of COVID-19.	
57	32565132	Journal Article;Research Support, N.I.H., Extramural;Research Support, NonU.S. Gov't;Review	O  NNLM;*COVID19;*CRS;*HLH;*IRIS;*SARSCoV2;*cellular therapy;*cytokine release;*hyperimmune response;*immunotherapy	Adrenal Cortex Hormones/therapeutic use;COVID19;Coronavirus Infections/drug therapy/*etiology/physiopathology;Cytokine Release Syndrome/etiology/therapy;Humans;Immune Reconstitution Inflammatory Syndrome/etiology/therapy;Immunization, Passive;Interleukin1/antagonists & inhibitors;Interleukin6/antagonists & inhibitors;Killer Cells, Natural/immunology;Lymphohistiocytosis, Hemophagocytic/etiology/therapy;Pandemics;Plasmapheresis;Pneumonia, Viral/*etiology/physiopathology;STAT Transcription Factors/antagonists & inhibitors;DA 2020/09/08 06:00		Emerging trends in COVID-19 treatment: learning from inflammatory conditions 	P30 CA008748/CA/NCI NIH HHS/United States
58	32532623	Journal Article;Review	O  NNLM;*COVID19;*Clinical trials;*NAATs;*SARSCoV2;*Spike protein;*Vaccine	Betacoronavirus/*drug effects/immunology/pathogenicity;COVID19;COVID19 Vaccines;Coronavirus/*drug effects;Coronavirus Infections/diagnosis/*drug therapy/*prevention & control/therapy;Humans;Immunization, Passive/methods;Pandemics/*prevention & control;Pneumonia, Viral/diagnosis/*drug therapy/*prevention & control;SARSCoV2;Viral Vaccines/*therapeutic use;DA 2020/10/30 06:00		Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines.	
59	32734518	Journal Article;Review	O  NNLM;COVID19;Coronaviruses;Drug classification;Pandemic;Pharmaceutical agents;Possible treatments;SARSCoV2	Animals;COVID19/*drug therapy/physiopathology/virology;Humans;Inflammation/drug therapy/physiopathology/virology;SARSCoV2/*drug effects/pathogenicity;DA 2020/12/15 06:00		Classification of the present pharmaceutical agents based on the possible effective 	
60	33493917	Journal Article;Review	O  NNLM;COVID19;Computational docking;Drug repurposing;SARSCoV2;Vaccine	Antiviral Agents/*therapeutic use;COVID19/*drug therapy/*prevention & control;*COVID19 Vaccines;Clinical Trials as Topic;Drug Repositioning;Humans;Pandemics;DA 2021/03/03 06:00		The growing complexity of COVID-19 drug and vaccine candidates: challenges and 	
61	33070079	Journal Article;Review	O  NNLM;Antiviral drugs;COVID19;Clinical trials;Drug repurposing;Monoclonal antibodies;SARSCoV2;Small molecule drugs;Vaccines	Antiviral Agents/*therapeutic use;COVID19/*drug therapy/epidemiology/prevention & control/*therapy;COVID19 Vaccines/*therapeutic use;Clinical Trials as Topic;Drug Repositioning;Humans;Pandemics/prevention & control;SARSCoV2;DA 2020/12/31 06:00		Primed for global coronavirus pandemic: Emerging research and clinical outcome.	
62	33239864	Journal Article;Review	O  NNLM;COVID19;anticancer drugs;drugrepurposing	Antineoplastic Agents/*therapeutic use;Antiviral Agents/therapeutic use;COVID19/*drug therapy;Clinical Trials as Topic;*Drug Repositioning;Humans;DA 2020/12/15 06:00		Repurposing Anti-Cancer Drugs for COVID-19 Treatment.	P30 CA086862/CA/NCI NIH HHS/United States;T32 GM007337/GM/NIGMS NIH HHS/United States
63	32511912	Journal Article;Research Support, NonU.S. Gov't;Review		Amino Acid Sequence;Animals;Antiviral Agents/*therapeutic use;COVID19/*drug therapy;Drug Repositioning;Enzyme Inhibitors/therapeutic use;Humans;Immunity, Innate/drug effects;SARSCoV2/*drug effects;DA 2020/12/15 06:00		COVID-19: Drug Targets and Potential Treatments.	
64	32290293	Journal Article;Review	O  NNLM;ACE2;COVID19;SARSCoV2;clinical trials;immunotherapy;pneumonia;replicase;vaccine	Antiviral Agents/*therapeutic use;*Betacoronavirus/chemistry/genetics/immunology/physiology;COVID19;COVID19 Vaccines;Clinical Trials as Topic;*Coronavirus Infections/diagnosis/drug therapy/epidemiology/prevention & ;Genome, Viral;Humans;Immunization, Passive;Immunologic Factors/*therapeutic use;*Pandemics;*Pneumonia, Viral/diagnosis/epidemiology/therapy/virology;SARSCoV2;*Viral Vaccines;DA 2020/04/17 06:00		A Review of SARS-CoV-2 and the Ongoing Clinical Trials.	
65	32565599	Journal Article;Review	O  NNLM;*Coronavirus disease19;*drug repurposing;*pandemic;*severe acute respiratory syndromecoronavirus2	Betacoronavirus/isolation & purification;COVID19;COVID19 Testing;COVID19 Vaccines;*Clinical Laboratory Techniques;Coronavirus Infections/diagnosis/drug therapy/epidemiology/prevention & ;Developing Countries;Disease Outbreaks;Drug Repositioning;Drug Therapy, Combination;Humans;India/epidemiology;Pandemics;Pneumonia, Viral/diagnosis/epidemiology/*therapy;SARSCoV2;Viral Vaccines/administration & dosage;DA 2020/07/01 06:00		COVID-19 pandemic: A review based on current evidence.	
66	33495752	Journal Article	O  NNLM;Anosmia;COVID19;Hyposmia;Ivermectin;SARSCoV2	DA 2021/01/27 06:01	ClinicalTrials.gov/NCT04390022	The effect of early treatment with ivermectin on viral load, symptoms and humoral 	
67	33390967	Journal Article;Review	O  NNLM;COVID19;SARSCoV2;antiviral;drug repurposing;prophylaxis	DA 2021/01/05 06:01		Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review.	
68	32947136	Journal Article;Research Support, NonU.S. Gov't;Review	O  NNLM;*Coronavirus;*RNA virus;*Respiratory disease;*SARSCoV2;*SARSCoV2 inhibitors	Amino Acid Sequence;Animals;Antiviral Agents/*therapeutic use;COVID19/*drug therapy/epidemiology;*Drug Discovery;Drug Repositioning;Humans;Pandemics;Protease Inhibitors/*therapeutic use;SARSCoV2/*drug effects;DA 2020/12/15 06:00		Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19.	U19 AI142759/AI/NIAID NIH HHS/United States
69	33442304	Journal Article;Review	O  NNLM;ARDS;SARSCoV2;chloroquine;heparin;remdesivir;steroids	DA 2021/01/15 06:01		Experimental Pharmacotherapy for COVID-19: The Latest Advances.	
70	32942671	Journal Article;Research Support, NonU.S. Gov't;Review	O  NNLM;*COVID19;*SARSCoV2;*Zika virus;*antiviral;*dengue virus;*flavivirus;*ivermectin	Animals;Antiviral Agents/*pharmacology;Betacoronavirus/*drug effects;COVID19;Cell Line;Chlorocebus aethiops;Coronavirus Infections/*drug therapy;Dengue/drug therapy;Dengue Virus/drug effects;HIV Infections/drug therapy;HIV Integrase/drug effects;HIV Integrase Inhibitors/pharmacology;HIV1/*drug effects;Humans;Ivermectin/*pharmacology;Pandemics;Pneumonia, Viral/*drug therapy;SARSCoV2;Vero Cells;Zika Virus/drug effects;Zika Virus Infection/drug therapy;DA 2020/09/29 06:00		Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?	Senior Principal Research Fellowship APP1002486/APP1103050/National Health and 
71	32468014	Journal Article;Review		Angiotensin II Type 1 Receptor Blockers/classification/therapeutic use;AngiotensinConverting Enzyme 2;Betacoronavirus/*drug effects/pathogenicity/physiology;Bromhexine/pharmacology/therapeutic use;COVID19;Chlorpromazine/pharmacology/therapeutic use;Clinical Trials as Topic/methods;Coronavirus Infections/*drug therapy/epidemiology/mortality;Diminazene/pharmacology/therapeutic use;*Drug Repositioning/methods/standards/trends;Gabexate/analogs & derivatives/pharmacology/therapeutic use;Humans;Pandemics;PeptidylDipeptidase A/chemistry/metabolism/therapeutic use;Pneumonia, Viral/*drug therapy/epidemiology/mortality;Receptor, Angiotensin, Type 1/metabolism;Recombinant Proteins/chemistry/therapeutic use;SARSCoV2;Signal Transduction/drug effects;Virus Internalization/*drug effects;DA 2020/07/02 06:00		Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights 	
72	32557011	Journal Article;Review	O  NNLM;COVID19;Complications;Potential cardiotoxicity;SARSCoV2	Antiviral Agents/*pharmacology;*COVID19/drug therapy/immunology;Cardiotoxicity/*prevention & control;Cardiovascular System/*drug effects;Humans;Immunologic Factors/*pharmacology;Risk Assessment;SARSCoV2/*drug effects;DA 2021/04/07 06:00		A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs.	
73	33086029	Journal Article;Review	O  NNLM;ACE2;ACEIs;ARBs and COVID19;RAS;SARSCoV2	Angiotensin Receptor Antagonists/*therapeutic use;AngiotensinConverting Enzyme 2/metabolism;AngiotensinConverting Enzyme Inhibitors/*therapeutic use;Animals;COVID19/*drug therapy/metabolism;Humans;ProtoOncogene Proteins/metabolism;Receptors, GProteinCoupled/metabolism;*ReninAngiotensin System;SARS Virus;*SARSCoV2/physiology;Severe Acute Respiratory Syndrome;DA 2020/12/30 06:00		Renin-angiotensin system at the interface of COVID-19 infection.	
74	32718020	Journal Article;Review	O  NNLM;ACE2;COVID19;SARSCoV2;TMPRSS2;coronavirus;endocytosis;spike protein;viral entry;viral fusion	Antibodies, Monoclonal/chemistry/pharmacology/therapeutic use;Antiviral Agents/chemistry/pharmacology/*therapeutic use;Betacoronavirus/drug effects/*physiology;COVID19;Clinical Trials as Topic;Coronavirus Infections/*drug therapy;Humans;Pandemics;Peptides/chemistry/pharmacology/therapeutic use;Pneumonia, Viral/*drug therapy;Polysaccharides/chemistry/pharmacology/therapeutic use;SARSCoV2;Small Molecule Libraries/chemistry/pharmacology/therapeutic use;Virus Attachment/drug effects;Virus Internalization/drug effects;DA 2020/08/13 06:00		Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life 	SC3GM131986; P20GM103424/GM/NIGMS NIH HHS/United States
75	33071609	Editorial		DA 2020/10/20 06:01		The Covid-19, Epidemiology, Clinic and Prevention.	
76	32838264	Journal Article;Review	O  NNLM;*coronavirus disease 2019;*placenta;*pregnancy;*severe acute respiratory syndrome coronavirus 2	Abnormalities, DrugInduced/etiology/*prevention & control;*Antiviral Agents/adverse effects/classification/pharmacokinetics;COVID19/*drug therapy;Compassionate Use Trials;*Drugs, Investigational/adverse effects/classification/pharmacokinetics;Female;Humans;*MaternalFetal Exchange;Pregnancy;Pregnancy Complications, Infectious/*drug therapy;SARSCoV2;DA 2020/08/25 06:01		Placental transfer and safety in pregnancy of medications under investigation to 	
77	33131530	Journal Article	O  NNLM;*COVID19;*Candidate drugs;*Infection pathways;*Interactome;*Prophylaxis agents;*Proteome;*SARSCoV2;*Transcriptome	*Antiviral Agents/chemistry/pharmacokinetics/therapeutic use;*Betacoronavirus/genetics/metabolism;COVID19;*Coronavirus Infections/drug therapy/genetics/metabolism;*Databases, Genetic;*Drug Discovery;Humans;*Models, Biological;*Pandemics;*Pneumonia, Viral/drug therapy/genetics/metabolism;Proteomics;SARSCoV2;DA 2020/11/18 06:00		Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs 	
78	32890967	Journal Article;Review	O  NNLM;Antiinflammatory;Antiviral;COVID19;PAK1 blocker;Propolis;SARSCoV2	Animals;Antiviral Agents/administration & dosage/*pharmacology;Betacoronavirus/drug effects/isolation & purification;COVID19;Coronavirus Infections/complications/*drug therapy/virology;Dietary Supplements;Functional Food;Humans;Macrophages/drug effects/immunology;Monocytes/drug effects/immunology;Pandemics;Pneumonia, Viral/complications/*drug therapy/virology;Propolis/administration & dosage/*pharmacology;SARSCoV2;DA 2020/11/11 06:00		Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 	
79	33347311	Journal Article;Research Support, NonU.S. Gov't;Review	O  NNLM;*SARSCoV2;*drug;*replication process;*target	AngiotensinConverting Enzyme 2/metabolism;Animals;Antiviral Agents/chemistry/*pharmacology;Basigin/metabolism;Coronavirus 3C Proteases/antagonists & inhibitors/metabolism;Coronavirus Nucleocapsid Proteins/chemistry/metabolism;Coronavirus RNADependent RNA Polymerase/metabolism;Dipeptidyl Peptidase 4/metabolism;Furin/antagonists & inhibitors/metabolism;HostPathogen Interactions/drug effects;Humans;SARSCoV2/*drug effects/pathogenicity/physiology;Serine Endopeptidases/metabolism;Small Molecule Libraries/pharmacology;Spike Glycoprotein, Coronavirus/chemistry/metabolism;Virus Replication/*drug effects;DA 2021/01/20 06:00		Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral 	
80	33123014	Journal Article;Review	O  NNLM;antimicrobial therapy;coronavirus disease 2019;drug;severe acute respiratory syndrome coronavirus 2;supportive therapy;vaccine	DA 2020/10/31 06:01		Available Compounds With Therapeutic Potential Against COVID-19: Antimicrobial 	
81	32993173	Journal Article;Research Support, N.I.H., Extramural;Review	O  NNLM;*COVID19;*EIDD2801;*RNAdependent RNA polymerase;*SARSCoV2;*dexamethasone;*dihydroorotate dehydrogenase;*favipiravir;*main protease;*papainlike protease;*remdesivir	Animals;AntiInflammatory Agents/therapeutic use;Antibodies, Monoclonal/therapeutic use;Antiviral Agents/chemistry/pharmacology/*therapeutic use;Betacoronavirus/*drug effects/physiology;COVID19;Clinical Trials as Topic;Coronavirus Infections/*drug therapy/virology;Drug Delivery Systems;Drug Development;Humans;Pandemics;Peptides/therapeutic use;Pneumonia, Viral/*drug therapy/virology;Protease Inhibitors/therapeutic use;SARSCoV2;DA 2020/11/03 06:00		Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the 	SC3GM131986/GM/NIGMS NIH HHS/United States;P20GM103424/GM/NIGMS NIH HHS/United States
82	32773165	Journal Article	O  NNLM;*COVID;*Hospitalizados;*Hospitalized;*Mortalidad;*Mortality;*SARSCoV2;*Tratamientos;*Treatments	Adrenal Cortex Hormones/therapeutic use;Angiotensin II Type 1 Receptor Blockers/therapeutic use;AngiotensinConverting Enzyme Inhibitors/therapeutic use;Antibodies, Monoclonal, Humanized/therapeutic use;Antiviral Agents/therapeutic use;Azithromycin/therapeutic use;*Betacoronavirus/drug effects;COVID19;Comorbidity;Coronavirus Infections/*drug therapy/mortality;Drug Therapy, Combination;Female;Humans;Hydroxychloroquine/therapeutic use;Inpatients/statistics & numerical data;Lopinavir/therapeutic use;Male;Pandemics;Pneumonia, Viral/*drug therapy/mortality;Proportional Hazards Models;Retrospective Studies;Ritonavir/therapeutic use;SARSCoV2;Spain;Treatment Outcome;DA 2020/11/20 06:00		Therapeutic agents tested in 238 COVID-19 hospitalized patients and their 	
83	32623267	Journal Article;Review	O  NNLM;COVID19;Coronavirus;Pandemic;Review;SARSCoV2	*Betacoronavirus/genetics/immunology/physiology;COVID19;Coronavirus Infections/diagnosis/epidemiology/immunology/*virology;Genome, Viral/genetics;HIV Infections/complications;Humans;Pandemics;Pneumonia, Viral/diagnosis/epidemiology/immunology/*virology;SARSCoV2;Virus Replication;DA 2020/08/18 06:00		Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus 	
84	32661214	Journal Article;Review		Adrenal Cortex Hormones/*therapeutic use;AngiotensinConverting Enzyme 2;Antiviral Agents/*therapeutic use;Betacoronavirus/drug effects/immunology/pathogenicity;COVID19;Coronavirus Infections/*drug therapy/epidemiology/immunology/virology;Disease Progression;Drug Discovery;*Drug Repositioning;Gene Expression Regulation;HostPathogen Interactions/drug effects/genetics/immunology;Humans;Hydroxychloroquine/therapeutic use;Immunologic Factors/*therapeutic use;Molecular Docking Simulation;Molecular Targeted Therapy/methods;*Pandemics;PeptidylDipeptidase A/genetics/immunology;Pneumonia, Viral/*drug therapy/epidemiology/immunology/virology;SARSCoV2;Signal Transduction/genetics/immunology;Spike Glycoprotein, Coronavirus/antagonists & inhibitors/genetics/immunology;DA 2020/07/22 06:00		Drug targets for COVID-19 therapeutics: Ongoing global efforts.	
85	33029696	Journal Article;Review	O  NNLM;ARDS;Cytokine storm syndrome;Herd immunity;Rheumatoid arthritis;Vaccine nationalism;Vertical transmission	AngiotensinConverting Enzyme 2/*genetics;COVID19/*drug therapy/genetics/therapy/virology;China;Chloroquine/therapeutic use;Drug Repositioning/methods;Humans;Immunization, Passive/methods;*Pandemics;SARSCoV2/*genetics/pathogenicity;DA 2021/02/13 06:00		Role of ACE2 receptor and the landscape of treatment options from convalescent 	TAR/2018/001054/Science and Engineering Research Board/
86	33072781	Systematic Review	O  NNLM;COVID19;SARSCoV2;antivirals;clinical trials;drug development;immunomodulators;research protocols	DA 2020/10/20 06:01		The Pipeline of Therapeutics Testing During the Emergency Phase of the COVID-19 	
87	32474009	Journal Article;Review	O  NNLM;COVID19;Prevention;SARSCoV2;Transmission;Treatment	Adrenal Cortex Hormones/therapeutic use;Antiviral Agents/therapeutic use;Betacoronavirus/*drug effects/pathogenicity;COVID19/*epidemiology/prevention & control/*therapy/transmission;COVID19 Vaccines;Clinical Trials as Topic;Coronavirus Infections/*epidemiology/prevention & control/*therapy/transmission;Drug Repositioning;Humans;Immunization, Passive/methods;Immunologic Factors/therapeutic use;Molecular Targeted Therapy/methods;*Pandemics/prevention & control;Personal Protective Equipment;Physical Distancing;Pneumonia, Viral/*epidemiology/prevention & control/*therapy/transmission;SARSCoV2;Viral Vaccines/biosynthesis;DA 2020/07/23 06:00		COVID-19: Transmission, prevention, and potential therapeutic opportunities.	
88	33199136	Journal Article;Review	O  NNLM;COVID19;Clinical trials;Pandemic;Repurposed medicine;SARSCoV2;Vaccine	DA 2020/11/18 06:00		In-line treatments and clinical initiatives to fight against COVID-19 outbreak.	
89	33264337	Journal Article;Multicenter Study;Randomized Controlled Trial;Research Support, NonU.S. Gov't		Adult;COVID19/*drug therapy;Female;Humans;Hydroxychloroquine/*adverse effects/*therapeutic use;Male;Middle Aged;Retrospective Studies;*Safety;Standard of Care;Treatment Outcome;Young Adult;DA 2020/12/15 06:00		A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and 	
90	33158234	Journal Article;Research Support, NonU.S. Gov't;Review	O  NNLM;*Traditional Chinese Medicines;*angiotensinconverting enzyme2;*antiviral;*epidemiology	Betacoronavirus;COVID19;Coronavirus Infections/*epidemiology/*therapy;Humans;Medicine, Chinese Traditional;Pandemics;Pneumonia, Viral/*epidemiology/*therapy;SARSCoV2;DA 2020/11/21 06:00		COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional 	
91	32334062	Journal Article;Research Support, NonU.S. Gov't;Review	O  NNLM;*ACE2 blocker;*Antimalaria;*Antiviral: Chinese traditional medicine;*COVID19;*Immunoenhancer;*Monoclonal antibody;*Vaccine	Adrenal Cortex Hormones/therapeutic use;AngiotensinConverting Enzyme 2;AntiInflammatory Agents, NonSteroidal/therapeutic use;Antibodies, Monoclonal, Humanized/therapeutic use;Anticoagulants/therapeutic use;Antimalarials/therapeutic use;Antiviral Agents/therapeutic use;Betacoronavirus;Bevacizumab/therapeutic use;COVID19;COVID19 Vaccines;Chloroquine/therapeutic use;Coronavirus Infections/drug therapy/prevention & control/*therapy;Humans;Hydroxychloroquine/therapeutic use;Immunization, Passive;Immunoglobulins, Intravenous/therapeutic use;Immunologic Factors/therapeutic use;Interferons/therapeutic use;Janus Kinase Inhibitors/therapeutic use;Killer Cells, Natural;Medicine, Chinese Traditional;Mesenchymal Stem Cell Transplantation;Nitric Oxide/therapeutic use;Pandemics;PeptidylDipeptidase A;Pneumonia, Viral/*therapy;SARSCoV2;Spike Glycoprotein, Coronavirus;Trace Elements/therapeutic use;Viral Vaccines/therapeutic use;Vitamins/therapeutic use;Zinc/therapeutic use;DA 2020/07/03 06:00		Current status of potential therapeutic candidates for the COVID-19 crisis.	
92	32607499	Journal Article;Review		DA 2020/07/02 06:01		Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a 	
93	33227285	Journal Article;Review	O  NNLM;Antiviral;COVID19;Clinical trials;Immunomodulation;Nitazoxanide;SARSCoV2	Antiprotozoal Agents/pharmacology;*COVID19/drug therapy/immunology;Clinical Trials as Topic;*Drug Repositioning;Humans;Immunity, Innate/drug effects;*SARSCoV2/drug effects/physiology;Thiazoles/*pharmacology;DA 2021/01/06 06:00		A review on possible mechanistic insights of Nitazoxanide for repurposing in 	
94	32603692	Journal Article;Review	O  NNLM;COVID19;Clinical trials;Coronavirus;Pharmacological treatments;SARSCoV2;Therapies	Adenosine Monophosphate/analogs & derivatives/pharmacology/therapeutic use;Adjuvants, Immunologic/*pharmacology/therapeutic use;Alanine/analogs & derivatives/pharmacology/therapeutic use;Antiviral Agents/*pharmacology/therapeutic use;Betacoronavirus/*drug effects/immunology/pathogenicity;COVID19;Clinical Trials as Topic;Coronavirus Infections/*drug therapy/epidemiology/virology;Glucocorticoids/pharmacology/therapeutic use;Heparin, LowMolecularWeight/pharmacology/therapeutic use;Humans;Hydroxychloroquine/pharmacology/therapeutic use;Immunity, Innate/drug effects;Inflammation Mediators/*pharmacology/therapeutic use;Oseltamivir/pharmacology/therapeutic use;Pandemics;Pneumonia, Viral/*drug therapy/epidemiology/virology;SARSCoV2;Treatment Outcome;DA 2020/08/08 06:00		Current pharmacological treatments for SARS-COV-2: A narrative review.	
95	33551661	Journal Article	O  NNLM;COVID19;Coronavirus;Multiple sequence alignment;Saudi Arabia;Tanshinones	DA 2021/02/09 06:01		Computational drug screening against the SARS-CoV-2 Saudi Arabia isolates through a 	
96	32696234	Journal Article;Review	O  NNLM;5fluorouracil;ACE2;ADAM17;Angiotensin receptor blockers;Antiandrogens;COVID19;Calmodulin antagonists;Camostat mesylate;Inhaled corticosteroids;Nafamostat mesylate;SARSCoV2;SERMs;TMPRSS2	ADAM17 Protein/metabolism;AngiotensinConverting Enzyme 2;Betacoronavirus;COVID19;Coronavirus Infections/*drug therapy/prevention & control;Humans;Pandemics/prevention & control;PeptidylDipeptidase A/*metabolism;Pneumonia, Viral/*drug therapy/prevention & control;SARSCoV2;Serine Endopeptidases/*metabolism;DA 2020/11/26 06:00		Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising 	
97	32898468	Journal Article	O  NNLM;*COVID19;*SARSCoV2;*chloroquine;*plasma therapy;*viraemia	Betacoronavirus/immunology/isolation & purification;COVID19;Clinical Trials as Topic;Coronavirus Infections/immunology/pathology/*therapy/virology;Humans;*Immunization, Passive;Pandemics;Pneumonia, Viral/pathology/*therapy/virology;SARSCoV2;Severity of Illness Index;DA 2020/09/17 06:00		Convalescent plasma therapy: a promising coronavirus disease 2019 treatment 	
98	33519949	Journal Article;Review	O  NNLM;COVID19;Coronavirus;Influenza, Pulmonary drug delivery;MERS, Nanomedicine;Nanotechnology;Nanotherapeutics;Pathophysiology;SARS, SARSCoV2	DA 2021/02/02 06:01		Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary 	
99	32437797	Journal Article;Review	O  NNLM;COVID19;Repurposing drugs;SARSCoV2;Spike proteins;Zoonotic origin	Animals;Betacoronavirus/isolation & purification;COVID19;Coronavirus Infections/*epidemiology/*therapy/virology;Pandemics/prevention & control;Pneumonia, Viral/*epidemiology/*therapy/virology;SARSCoV2;Zoonoses/epidemiology/therapy/virology;DA 2020/06/23 06:00		The current understanding and potential therapeutic options to combat COVID-19.	
100	33234158	Letter;Randomized Controlled Trial	O  NNLM;COVID19;Hospitalization;Ivermectin;Protocol;Randomized controlled trial	Adult;Antiparasitic Agents/administration & dosage/*therapeutic use;Argentina/epidemiology;COVID19/*drug therapy/epidemiology/virology;CaseControl Studies;DoubleBlind Method;Female;Hospitalization/statistics & numerical data;Humans;Ivermectin/administration & dosage/*therapeutic use;Male;Pandemics/prevention & control;Placebos/administration & dosage;Prospective Studies;SARSCoV2/*genetics;Time Factors;DA 2020/12/15 06:00	ClinicalTrials.gov/NCT04529525	Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): 	
101	33330858	Preprint		DA 2020/12/18 06:01		Drug Repurposing for COVID-19 using Graph Neural Network with Genetic, Mechanistic, 	R01 AG066749/AG/NIA NIH HHS/United States;R01 LM012806/LM/NLM NIH HHS/United States
102	33096261	Editorial	O  NNLM;*COVID19;*SARSCoV2;*antiinfective agents;*antiparasitic agent;*antiviral agent;*antibiotic agent	Adenosine Monophosphate/analogs & derivatives/therapeutic use;Alanine/analogs & derivatives/therapeutic use;AntiBacterial Agents/therapeutic use;Antiparasitic Agents/therapeutic use;Antiviral Agents/*therapeutic use;COVID19/*drug therapy;Drug Development/*trends;*Drug Repositioning;Humans;*SARSCoV2/physiology;Virus Physiological Phenomena;DA 2020/12/29 06:00		Anti-infective therapy against SARS-CoV-2: some light at the end of the tunnel?	
103	33534108	Letter	O  NNLM;*COVID19;*Doxycycline;*Drug repurposing;*Minocycline;*Neuroinflammation;*SARSCoV2 infection	AntiInflammatory Agents/*administration & dosage;Antiviral Agents/administration & dosage;COVID19/*drug therapy/epidemiology/immunology;Drug Repositioning/*methods;Humans;Inflammation Mediators/antagonists & inhibitors/immunology;Mental Disorders/*drug therapy/epidemiology/immunology;Nervous System Diseases/*drug therapy/epidemiology/immunology;Tetracyclines/*administration & dosage;DA 2021/05/11 06:00		Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric 	
104	33027420	Journal Article		Betacoronavirus;COVID19;Coronavirus Infections/*drug therapy;*Drug Discovery;*Drug Repositioning;Humans;Pandemics;Pneumonia, Viral/*drug therapy;SARSCoV2;DA 2020/10/10 06:00		COVID-19: molecular targets, drug repurposing and new avenues for drug discovery.	
105	32485970	Journal Article;Review	O  NNLM;COVID19;SARSCoV2;animal models;antivirals	DA 2020/06/04 06:01		A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral 	
106	32580969	Journal Article;Review	O  NNLM;COVID19;One Health;SARSCoV2;diagnosis;emerging coronavirus;therapy;vaccines	Animals;Betacoronavirus/physiology;COVID19;*Coronavirus Infections/diagnosis/epidemiology/therapy/virology;Humans;*Pandemics;*Pneumonia, Viral/diagnosis/epidemiology/therapy/virology;SARSCoV2;DA 2020/07/09 06:00		Coronavirus Disease 2019-COVID-19.	
107	33022293	Journal Article;Review	O  NNLM;*COVID19;*Prophylaxis;*Repurposed chemotherapy;*SARSCoV2	COVID19/*prevention & control;Clinical Protocols;*Clinical Trials as Topic;Humans;*PostExposure Prophylaxis;*PreExposure Prophylaxis;SARSCoV2;DA 2021/05/25 06:00		Clinical trial protocols of repurposed prophylaxis for COVID-19: A review.	
108	33321790	Journal Article;Research Support, NonU.S. Gov't;Review	O  NNLM;*nuclear export inhibitors;*nuclear export sequence;*nuclear import inhibitors;*nuclear import sequence;*nuclear transport receptors;*nucleoporins;*protein intrinsic disorder;*viral infection	Active Transport, Cell Nucleus;Animals;Cell Nucleus/*metabolism;Humans;Protein Stability;Viral Proteins/chemistry/*metabolism;Virus Replication;DA 2021/03/23 06:00		The Role of Protein Disorder in Nuclear Transport and in Its Subversion by Viruses.	
109	33253764	Journal Article;Review	O  NNLM;Biologics;Covid19;Drug design;Food and nutrients;Natural products;Repurposed drugs;SARSCoV2;Vaccines	Antiviral Agents/*pharmacology;Biological Products;COVID19/*drug therapy;Drug Design;Drug Discovery;Humans;Pandemics;SARSCoV2/chemistry/*drug effects/ultrastructure;DA 2021/01/08 06:00		Exploring the magic bullets to identify Achilles' heel in SARS-CoV-2: Delving deeper 	
110	33133697	Journal Article;Review		DA 2020/11/03 06:01		Stopping the COVID-19 Pandemic: A Review on the Advances of Diagnosis, Treatment, 	
111	33341233	Journal Article;Research Support, NonU.S. Gov't;Review	O  NNLM;*Antiviral;*COVID19;*Dengue virus;*Ivermectin;*SARSCoV2;*Zika virus	Antiparasitic Agents/*pharmacology/therapeutic use;Antiviral Agents/*pharmacology/therapeutic use;COVID19/*drug therapy;Humans;Ivermectin/*pharmacology/therapeutic use;SARSCoV2/*drug effects;alpha Karyopherins/antagonists & inhibitors;DA 2021/03/09 06:00		The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?	
112	32395418	Journal Article;Review	O  NNLM;Anakinra;Azithromycin;COVID19;Chloroquine;Convalescent plasma;Epoprostenol;Favipiravir;Hydroxychloroquine;Lopinavir;Methylprednisolone;Nitric oxide;Oseltamivir;Remdesivir;SARCoV2;Sarilumab;Sirolimus;Tocilizumab;Traditional Chinese Medicine;Umifenovir;Vitamin C	DA 2020/05/13 06:00		An Update on Current Therapeutic Drugs Treating COVID-19.	
113	32710969	Journal Article;Research Support, NonU.S. Gov't;Review	O  NNLM;*Antiviral agents;*COVID19;*Coronavirus;*Cytokine storm;*Drug repositioning;*SARSCoV2	Animals;Antiviral Agents/*pharmacology/therapeutic use;Betacoronavirus/*drug effects;COVID19;Cardiovascular Diseases/drug therapy/virology;*Clinical Trials as Topic;Coronavirus Infections/complications/*drug therapy;Cytokines/metabolism;*Drug Repositioning;Humans;Outcome and Process Assessment, Health Care;Pandemics;Pneumonia, Viral/complications/*drug therapy;SARSCoV2;DA 2020/11/18 06:00		Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with 	
114	33348292	Journal Article;Review	O  NNLM;Antiviral;COVID19;Immune system;Interferon;Pandemic;Severe acute respiratory syndrome coronavirus 2	Animals;Antiviral Agents/*pharmacology/*therapeutic use;COVID19/*drug therapy/virology;Humans;Interferon Type I/*pharmacology/*therapeutic use;Pandemics/prevention & control;SARSCoV2/*drug effects;DA 2021/02/03 06:00		Interferon-inducer antivirals: Potential candidates to combat COVID-19.	
115	33519133	Journal Article	O  NNLM;Covid 19;Siddha strategy;accelerated recovery;synergistic effect	DA 2021/02/02 06:00		An Open Clinical Evaluation Of Selected Siddha Regimen In Expediting The Management 	
116	33227708	Journal Article;Review	O  NNLM;Azithromycin;COVID19;Chloroquine/hydroxychloroquine;Interferons;Treatment;Vaccine	Antiviral Agents/*therapeutic use;Azithromycin/*therapeutic use;COVID19/*prevention & control;COVID19 Vaccines/*therapeutic use;Chloroquine/*therapeutic use;Humans;Hydroxychloroquine/therapeutic use;Interferons/*therapeutic use;Treatment Outcome;DA 2021/01/01 06:00		Prevention and treatment of COVID-19: Focus on interferons, 	
117	33014380	Journal Article;Review	O  NNLM;2019nCoV;Coronavirus 2019;WHO;drugs;global tally;severe acute respiratory syndrome coronavirus 2	DA 2020/10/06 06:01		Diagnostic approaches and potential therapeutic options for coronavirus disease 	
118	32935090	Preprint		DA 2020/09/17 06:01		Patient-Reported Health Outcomes After Treatment of COVID-19 with Nebulized and/or 	
119	32654267	Journal Article;Review	O  NNLM;*COVID19 pneumonia;*animal models and immunotherapy;*diagnosis;*entry mechanism;*possible vaccines;*symptoms;*transmission	Animals;Antiviral Agents/therapeutic use;COVID19/*pathology/prevention & control/therapy/transmission;Humans;*Immunotherapy;Middle East Respiratory Syndrome Coronavirus/genetics/isolation & ;Models, Animal;Respiratory Tract Infections/*pathology/transmission/virology;SARSCoV2/genetics/isolation & purification/pathogenicity;Viral Vaccines/*immunology;DA 2020/12/15 06:00		The recent challenges of highly contagious COVID-19, causing respiratory infections: 	
120	32569708	Journal Article;Review	O  NNLM;*Baricitinib;*COVID19;*Coagulation;*Coronavirus;*Dexamethasone;*Drugs;*Eculizumab;*Emapalumab;*Inflammation;*Remdesivir;*Ruxolitinib;*SARSCoV1;*SARSCoV2;*Therapies;*Tocilizumab;*Treatment	Adenosine Monophosphate/analogs & derivatives/therapeutic use;Alanine/analogs & derivatives/therapeutic use;AntiInflammatory Agents/*therapeutic use;Antibodies, Monoclonal/therapeutic use;Antibodies, Monoclonal, Humanized/therapeutic use;Antibodies, Neutralizing/therapeutic use;Anticoagulants/*therapeutic use;Antiviral Agents/*therapeutic use;Azetidines/therapeutic use;Betacoronavirus/*drug effects/immunology;COVID19;Coronavirus Infections/*drug therapy/virology;Cytokine Release Syndrome/*drug therapy/virology;Disseminated Intravascular Coagulation/*drug therapy/virology;Drug Combinations;Heparin/therapeutic use;Humans;Hydroxychloroquine/therapeutic use;Inflammation;Interleukin 1 Receptor Antagonist Protein/therapeutic use;Lopinavir/therapeutic use;Pandemics;Pneumonia, Viral/*drug therapy/virology;Ritonavir/therapeutic use;SARSCoV2;Sulfonamides/therapeutic use;DA 2020/09/09 06:00		COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. 	
121	33551672	Journal Article;Review	O  NNLM;Batlike CoV;In silico analyses;MERSCoV;Pangolin CoV;SARSCoV;nCoV	DA 2021/02/09 06:00		The COVID-19 puzzle: a global nightmare.	
122	33249292	Letter		DA 2020/11/30 06:00		Repurposing medications.	
123	32397911	Journal Article;Review	O  NNLM;*COVID19;*SARSCoV2;*infection;*repurposed therapies;*vaccine;*viruses	Antiviral Agents/therapeutic use;*Betacoronavirus/genetics;COVID19;COVID19 Testing;COVID19 Vaccines;Clinical Laboratory Techniques;Coronavirus/genetics;*Coronavirus Infections/diagnosis/drug ;Disease Progression;Humans;*Pandemics/prevention & control;*Pneumonia, Viral/diagnosis/epidemiology/prevention & control/therapy;RNA, Viral;SARSCoV2;*Viral Vaccines/genetics/immunology;DA 2020/05/23 06:00		COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and 	
124	33542677	Journal Article		DA 2021/02/06 06:01		Ivermectin: Panacea or true promise for COVID-19.	
125	32441741	Comment;Journal Article		Betacoronavirus;COVID19;Coronavirus Infections;Edetic Acid;Expert Testimony;Humans;Immunosuppression;*Kidney Transplantation;Pandemics;Pneumonia, Viral;SARSCoV2;Transplant Recipients;DA 2020/06/18 06:00		How should I manage immunosuppression in a kidney transplant patient with COVID-19? 	
126	33486202	Journal Article;Review	O  NNLM;Angiotensinconverting enzyme 2;COVID19;Main and papainlike proteases;RNAdependentRNApolymerase;Repurposing and de novo strategies;Spike protein	Antiviral Agents/*pharmacology;*COVID19/drug therapy/epidemiology;Drug Development/methods;Drug Repositioning/methods;Humans;*SARSCoV2/drug effects/physiology;Treatment Outcome;Viral Proteins/antagonists & inhibitors/genetics;Virus Internalization/drug effects;DA 2021/04/07 06:00		Human endeavor for anti-SARS-CoV-2 pharmacotherapy: A major strategy to fight the 	
127	32616710	Journal Article;Research Support, NonU.S. Gov't;Review		DA 2020/07/04 06:00		Overcoming cancer therapeutic bottleneck by drug repurposing.	
128	32837982	Journal Article;Review	O  NNLM;COVID19;Chloroquine;Coronavirus;Famotidine;Ivermectin;Nicotine;Remdesivir;SARSCov2	DA 2020/08/25 06:01		Known drugs and small molecules in the battle for COVID-19 treatment.	
129	32693298	Journal Article;Review	O  NNLM;Antiviral drugs;Bioactivity scores;COVID19;In silico ADMET properties;Lipinski’s parameters;SARSCoV2	Animals;Antiviral Agents/pharmacokinetics/*therapeutic use;Betacoronavirus/*drug effects;Biological Availability;COVID19;COVID19 Vaccines;Coronavirus Infections/*drug therapy/prevention & control;Drug Combinations;Humans;Pandemics;Pneumonia, Viral/*drug therapy;SARSCoV2;Viral Vaccines;DA 2020/09/25 06:00		COVID-19 treatment: Much research and testing, but far, few magic bullets against 	
130	32817953	Preprint		DA 2020/08/21 06:01		Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in 	R35 GM119617/GM/NIGMS NIH HHS/United States
131	33123144	Journal Article;Review	O  NNLM;*ACE2;*COVID19;*EMMPRIN;*SARSCoV2;*monoclonal antibodies;*nonstructural protein;*remdesivir;*spike receptor	Adenosine Monophosphate/analogs & derivatives/therapeutic use;Alanine/analogs & derivatives/therapeutic use;AngiotensinConverting Enzyme 2;Antibodies, Monoclonal/therapeutic use;Antibodies, Viral/therapeutic use;Antiviral Agents/*therapeutic use;Betacoronavirus/*drug effects/genetics/immunology;COVID19;COVID19 Testing;Clinical Laboratory Techniques/*methods;*Coronavirus Infections/diagnosis/pathology/therapy;Disease Reservoirs/virology;Drug Repositioning/methods;Humans;Immunoenzyme Techniques;Immunotherapy;*Pandemics;PeptidylDipeptidase A/metabolism;*Pneumonia, Viral/diagnosis/pathology/therapy;Receptors, Virus/metabolism;Reverse Transcriptase Polymerase Chain Reaction;SARSCoV2;Serologic Tests/methods;Spike Glycoprotein, Coronavirus/metabolism;DA 2020/11/11 06:00		SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment.	
132	33041830	Journal Article;Review	O  NNLM;antiinflammatory;antiviral;coronavirus disease 2019;drug repurposing;immunotherapy;pathophysiology;severe acute respiratory syndrome coronavirus 2	DA 2020/10/13 06:01		Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly 	
133	32472459	Journal Article;Review	O  NNLM;Algorithm;COVID19;Management;SarsCoV2	Algorithms;*Antiviral Agents/immunology/pharmacology;Betacoronavirus/isolation & purification;COVID19;COVID19 Testing;Clinical Laboratory Techniques/*methods;*Coronavirus Infections/diagnosis/drug therapy/epidemiology/immunology/therapy;Critical Pathways;*Cytokine Release Syndrome/diagnosis/drug therapy/etiology;Humans;*Pandemics;Patient Care Team/*organization & administration;*Pneumonia, Viral/epidemiology/immunology/therapy;SARSCoV2;DA 2020/06/25 06:00		Treatment algorithm for COVID-19: a multidisciplinary point of view.	
134	32987852	Journal Article;Review	O  NNLM;COVID19;SARSCoV2;immune response;inflammation	DA 2020/09/30 06:01		SARS-CoV-2: From Structure to Pathology, Host Immune Response and Therapeutic 	13SOL/Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, 
135	32864299	Journal Article;Review	O  NNLM;COVID19;Coronavirus;Hydroxychloroquine;Pandemic;QT prolongation;SARSCoV2	DA 2020/08/31 06:00		Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2.	
136	32433345	Journal Article;Review		Active Transport, Cell Nucleus/drug effects;Antibodies, Monoclonal/therapeutic use;Antiviral Agents/*therapeutic use;*Betacoronavirus/genetics;COVID19;Coronavirus Infections/*drug therapy;*Drug Development;Genome, Viral;Humans;Killer Cells, Natural/immunology;Pandemics;Pneumonia, Viral/*drug therapy;SARSCoV2;DA 2020/09/01 06:00		The pharmacological development of direct acting agents for emerging needed therapy 	
137	33065092	Journal Article;Review	O  NNLM;COVID19;Convalescent plasma therapy and mesenchymal stem cell therapy;Coronavirus;Drug repurposing;SARSCOV2;Vaccines	Animals;Antiviral Agents/*therapeutic use;COVID19/*drug therapy/*epidemiology;Humans;*Pandemics;*SARSCoV2;DA 2020/12/29 06:00		Pharmacological insight into potential therapeutic agents for the deadly Covid-19 	
